Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Escherichia coli infections
MeSH D004927 - escherichia coli infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004756:
Enterobacteriaceae infections
38 Companies
7 Drugs
$
Success rate
D004927:
Escherichia coli infections
178 Companies
96 Drugs
$
Success rate
D020814:
Escherichia coli meningitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/2
Phase 2
100
%
2/2
Phase 3
99
%
76/77
Approved:
75
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Alcon Research
Dexamethasone
Allergan
Avibactam
,
Ceftazidime
,
Ciprofloxacin
,
Gatifloxacin
,
Hydrocortisone
,
Hydrocortisone butyrate
,
Hydrocortisone probutate
,
Levofloxacin
,
Minocycline
,
Ofloxacin
,
Prednisolone
,
Prednisolone tebutate
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use